// App-Quantinova.ai

OP0254 (2018) : A propensity score-matched (PSM analysis of organ damage in patients with systemic lupus erythematosus (SLE from the pooled bliss long-term extension (LTE trials versus the toronto lupus cohort (TLC

Researchers

Presenter

  • M. Urowitz

Principal Investigators

  • R.L. Ohsfeldt

  • R.C. Wielage

  • J.J. Dever

  • M. Zakerifar

  • Y. Asukai

  • S. Ramachandran

  • A.V. Joshi

Medical Centers

  • Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

  • Medical Decision Modeling Inc., Indianapolis, IN

  • Value Evidence and Outcomes, GSK, Brentford, UK

  • Value Evidence and Outcomes, GSK, Philadelphia, PA, USA

Locations

  • Canada

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • Folate Hydrolase 1

Drug/Treatment

  • Belimumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GlaxoSmithKline (GSK)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved